We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
Cap. Flow
+$2B
Cap. Flow %
3.34%
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$134M
2
MSFT icon
Microsoft
MSFT
+$119M
3
AAPL icon
Apple
AAPL
+$87.6M
4
ABBV icon
AbbVie
ABBV
+$61.7M
5
META icon
Meta Platforms (Facebook)
META
+$54.9M

Sector Composition

Rank Sector Weight
1 Technology 23.43%
2 Healthcare 14.28%
3 Financials 13.11%
4 Consumer Discretionary 10.94%
5 Communication Services 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GYRE icon
2901
Gyre Therapeutics
GYRE
$744M
$127K ﹤0.01%
+2,895
New +$136K
HOOK
2902
DELISTED
HOOKIPA Pharma
HOOK
$127K ﹤0.01%
+1,093
New +$107K
CDR
2903
DELISTED
Cedar Realty Trust, Inc
CDR
$127K ﹤0.01%
19,504
-31,818
-62% -$196K
DLTH icon
2904
Duluth Holdings
DLTH
$159M
$125K ﹤0.01%
16,906
+4,405
+35% +$22.5K
NYMX
2905
DELISTED
Nymox Pharmaceutical Corp
NYMX
$124K ﹤0.01%
+34,839
New +$110K
HBB icon
2906
Hamilton Beach Brands
HBB
$422M
$122K ﹤0.01%
+10,234
New +$112K
AUO
2907
DELISTED
AU Optronics Corp
AUO
$122K ﹤0.01%
+39,994
New +$122K
XCUR icon
2908
Exicure
XCUR
$8.54M
$121K ﹤0.01%
+329
New +$119K
XERS icon
2909
Xeris Biopharma Holdings
XERS
$1.45B
$121K ﹤0.01%
45,453
+14,269
+46% +$49.7K
APTX
2910
DELISTED
Aptinyx Inc. Common Stock
APTX
$121K ﹤0.01%
+29,012
New +$98.2K
III icon
2911
Information Services Group
III
$251M
$120K ﹤0.01%
58,141
+5,010
+9% +$10.7K
SCTL
2912
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$120K ﹤0.01%
26,451
+972
+4% +$6.01K
GDYN icon
2913
Grid Dynamics Holdings
GDYN
$615M
$119K ﹤0.01%
+17,190
New +$141K
MG icon
2914
Mistras Group
MG
$512M
$119K ﹤0.01%
30,209
+2,610
+9% +$10.8K
PBFS icon
2915
Pioneer Bancorp
PBFS
$434M
$119K ﹤0.01%
+13,011
New +$121K
MR
2916
DELISTED
Montage Resources Corporation Common Stock
MR
$119K ﹤0.01%
30,095
+3,923
+15% +$20K
FNCB
2917
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$118K ﹤0.01%
20,518
-3,511
-15% -$21.2K
CRC
2918
DELISTED
California Resources Corporation
CRC
$118K ﹤0.01%
97,095
-15,299
-14% -$25.9K
EARN
2919
Ellington Residential Mortgage REIT
EARN
$165M
$117K ﹤0.01%
+11,354
New +$102K
FLNT
2920
Fluent
FLNT
$120M
$116K ﹤0.01%
10,871
+2,615
+32% +$29.3K
PXLW icon
2921
Pixelworks
PXLW
$41.6M
$116K ﹤0.01%
+2,989
New +$129K
SRT
2922
DELISTED
Startek Inc.
SRT
$114K ﹤0.01%
22,389
+2,445
+12% +$9.65K
AGFS
2923
DELISTED
AgroFresh Solutions Inc
AGFS
$114K ﹤0.01%
+37,470
New +$92.8K
LOGC
2924
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$114K ﹤0.01%
13,520
+3,320
+33% +$21.8K
PVBC
2925
DELISTED
Provident Bancorp
PVBC
$113K ﹤0.01%
14,327
+1,158
+9% +$10K

Similar funds

RhumbLine Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.

  • RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
  • RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
  • RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
  • RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
  • RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
  • RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.

Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.